INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)

$44.15 -0.35 (-0.7865%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 77

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) News Sources

Immune Resetting: B-Cell Mediated & Beyond Summit 2026 Oral Presentation: Innovent Biologics Announces Pre-Clinical Results of IBI3055, a Tri-specific T Cell Engager Targeting Autoimmune Diseases

10-04-2026

yahoo.com

Altruist Biologics' Hangzhou Facility Secures First Commercial Manufacturing License

08-04-2026

yahoo.com

Assessing Innovent Biologics (SEHK:1801) Valuation After Strong Recent Share Price Momentum

04-04-2026

yahoo.com

Lilly's $2 Billion AI Deal Raises Stakes

31-03-2026

yahoo.com

Innovent's Partner Ollin Biosciences Announces Final Data from Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

31-03-2026

yahoo.com

Ollin Biosciences Announces Final Data From Randomized Head-to-Head Study of OLN324 Compared to Faricimab (Vabysmo®) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema

30-03-2026

yahoo.com

Innovent Announces 2025 Annual Results and Business Updates

26-03-2026

yahoo.com

The Phase 3 Registration STAR Study of Efdamrofusp Alfa (IBI302) Met its Primary Endpoint, Making it the First Self-developed Extended-interval Treatment for nAMD in China

24-03-2026

yahoo.com

Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study

23-03-2026

yahoo.com

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

02-03-2026

yahoo.com

IVBIY stock
IVBIY stock price
IVBIY stock price today
IVBIY stock prediction
IVBIY earnings date
IVBIY news
IVBIY price
IVBIY share
IVBIY share price
IVBIY shares
IVBIY ceo
IVBIY premarket
$IVBIY
IVBIY ticker
IVBIY after hours
IVBIY stock
IVBIY stock price
IVBIY stock price today
IVBIY stock prediction
IVBIY earnings date
IVBIY news
IVBIY price
IVBIY share
IVBIY share price
IVBIY shares
IVBIY ceo
IVBIY premarket
$IVBIY
IVBIY ticker
IVBIY after hours

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) Sentiment Trend

View FAQ

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) FAQs

toggle

What is the current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The current price of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is $44.15.


toggle

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) absolute price change since previous trading day?

The absolute price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is $-0.35.


toggle

INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) percentage price change since previous trading day?

The percentage price change of INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) since the previous trading day is -0.7865%.


toggle

What is the most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The most recent average sentiment score for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is 77 out of 100.


toggle

What is the most recent average sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)?

The most recent sentiment for INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS) is .


SEC-8K** Filing Available For INNOVENT BIOLOGICS INC-ADR (IVBIY:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.